Evolent Health, Inc. (EVH) Downgraded to Hold by Truist Securities
Rating Change Truist Securities analysts downgraded Evolent Health, Inc. (NYSE:EVH) from Buy to Hold on June 30, 2026. Market Context Evolent Health, Inc.
Read moreReal-time context
Upgrades, downgrades, initiations, and price-target changes.
Rating Change Truist Securities analysts downgraded Evolent Health, Inc. (NYSE:EVH) from Buy to Hold on June 30, 2026. Market Context Evolent Health, Inc.
Read moreRating Change Baird analysts reiterated a Outperform rating on Taysha Gene Therapies, Inc. (NASDAQ:TSHA) on June 30, 2026. Market Context Taysha Gene Therapies, Inc.
Read moreRating Change Cantor Fitzgerald analysts reiterated a Overweight rating on BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) on June 30, 2026. Market Context BioCryst Pharmaceuticals,…
Read moreRating Change HC Wainwright & Co. analysts reiterated a Buy rating on BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) on June 30, 2026.
Read moreRating Change Morgan Stanley analysts reiterated a Equal-Weight rating on Hertz Global Holdings, Inc. (NASDAQ:HTZ) on June 30, 2026. Market Context Hertz Global Holdings, Inc.
Read moreRating Change Needham analysts reiterated a Buy rating on Viridian Therapeutics, Inc. (NASDAQ:VRDN) on June 30, 2026. Market Context Viridian Therapeutics, Inc.
Read moreRating Change Truist Securities analysts reiterated a Buy rating on Viridian Therapeutics, Inc. (NASDAQ:VRDN) on June 30, 2026. Market Context Viridian Therapeutics, Inc.
Read moreRating Change Wedbush analysts reiterated a Outperform rating on Viridian Therapeutics, Inc. (NASDAQ:VRDN) on June 30, 2026. Market Context Viridian Therapeutics, Inc.
Read moreRating Change Freedom Broker analysts initiated coverage on American States Water Company (NYSE:AWR) with a Hold rating on June 30, 2026. Market Context American States Water…
Read moreRating Change Barclays analysts initiated coverage on Hawkins, Inc. (NASDAQ:HWKN) with a Equal-Weight rating on June 30, 2026. Market Context Hawkins, Inc.
Read moreRating Change Goldman Sachs analysts reiterated a Buy rating on Hamilton Lane Incorporated (NASDAQ:HLNE) on June 30, 2026. Market Context Hamilton Lane Incorporated operates in…
Read moreRating Change Argus Research analysts reiterated a Buy rating on International Flavors & Fragrances Inc. (NYSE:IFF) on June 30, 2026. Market Context International Flavors &…
Read moreRating Change HSBC analysts downgraded Fortinet, Inc. (NASDAQ:FTNT) from Hold to Reduce on June 30, 2026. Market Context Fortinet, Inc.
Read moreRating Change Citigroup analysts downgraded Truist Financial Corporation (NYSE:TFC) from Buy to Neutral on June 30, 2026. Market Context Truist Financial Corporation operates in…
Read moreRating Change Freedom Broker analysts upgraded Satellogic Inc. (NASDAQ:SATL) from Hold to Buy on June 29, 2026. Market Context Satellogic Inc.
Read moreRating Change Jones Trading analysts reiterated a Buy rating on Enliven Therapeutics, Inc. (NASDAQ:ELVN) on June 29, 2026. Market Context Enliven Therapeutics, Inc.
Read moreRating Change Citizens analysts initiated coverage on Lucky Strike Entertainment Corporation (NYSE:LUCK) with a Market Perform rating on June 29, 2026. Market Context Lucky Strike…
Read moreRating Change Morgan Stanley analysts reiterated a Equal-Weight rating on Bank OZK (NASDAQ:OZKAP) on June 29, 2026. Market Context Bank OZK operates in the Financial Services…
Read moreRating Change Guggenheim analysts reiterated a Buy rating on Twist Bioscience Corporation (NASDAQ:TWST) on June 29, 2026. Market Context Twist Bioscience Corporation operates in…
Read moreRating Change B of A Securities analysts reiterated a Buy rating on InvenTrust Properties Corp. (NYSE:IVT) on June 29, 2026. Market Context InvenTrust Properties Corp.
Read more